Virginia Retirement Systems’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $46.7M | Hold |
94,060
| – | – | 0.28% | 95 |
|
|
2026
Q1 | $42M | Buy |
94,060
+56,960
| +154% | +$26.6M | 0.31% | 98 |
|
|
2025
Q4 | $16.8M | Hold |
37,100
| – | – | 0.1% | 199 |
|
|
2025
Q3 | $14.5M | Buy |
+37,100
| New | +$15.5M | 0.09% | 205 |
|
|
2025
Q2 | – | Sell |
-43,500
| Closed | -$21.1M | – | 1083 |
|
|
2025
Q1 | $21.1M | Buy |
+43,500
| New | +$20.3M | 0.16% | 165 |
|
|
2023
Q3 | $104M | Hold |
297,900
| – | – | 1.02% | 13 |
|
|
2023
Q2 | $105M | Buy |
297,900
+3,900
| +1% | +$1.31M | 1.01% | 14 |
|
|
2023
Q1 | $92.6M | Buy |
294,000
+23,800
| +9% | +$7.14M | 0.96% | 17 |
|
|
2022
Q4 | $78M | Sell |
270,200
-4,300
| -2% | -$1.31M | 0.81% | 18 |
|
|
2022
Q3 | $79.5M | Buy |
+274,500
| New | +$79M | 0.9% | 21 |
|
|
2022
Q1 | $74.3M | Sell |
284,800
-16,100
| -5% | -$3.82M | 0.7% | 24 |
|
|
2021
Q4 | $66.1M | Sell |
300,900
-5,800
| -2% | -$1.13M | 0.45% | 38 |
|
|
2021
Q3 | $55.6M | Buy |
306,700
+19,900
| +7% | +$3.89M | 0.57% | 38 |
|
|
2021
Q2 | $57.8M | Sell |
286,800
-500
| -0.2% | -$105K | 0.57% | 43 |
|
|
2021
Q1 | $61.7M | Buy |
287,300
+168,100
| +141% | +$36.9M | 0.6% | 39 |
|
|
2020
Q4 | $28.2M | Buy |
119,200
+47,400
| +66% | +$10.9M | 0.3% | 88 |
|
|
2020
Q3 | $19.5M | Sell |
71,800
-1,800
| -2% | -$497K | 0.22% | 114 |
|
|
2020
Q2 | $21.4M | Sell |
73,600
-100
| -0.1% | -$27.1K | 0.25% | 96 |
|
|
2020
Q1 | $17.5M | Buy |
73,700
+5,400
| +8% | +$1.24M | 0.24% | 106 |
|
|
2019
Q4 | $15M | Buy |
68,300
+31,200
| +84% | +$6.31M | 0.16% | 176 |
|
|
2019
Q3 | $6.29M | Buy |
37,100
+600
| +2% | +$106K | 0.07% | 293 |
|
|
2019
Q2 | $6.69M | Buy |
+36,500
| New | +$6.38M | 0.08% | 272 |
|
|
2018
Q4 | – | Sell |
-3,500
| Closed | -$675K | – | 1128 |
|
|
2018
Q3 | $675K | Hold |
3,500
| – | – | 0.01% | 836 |
|
|
2018
Q2 | $595K | Buy |
+3,500
| New | +$543K | 0.01% | 853 |
|
|
2015
Q4 | $655K | Buy |
5,202
+68
| +1% | +$8.21K | 0.01% | 665 |
|
|
2015
Q3 | $535K | Buy |
5,134
+87
| +2% | +$11.2K | 0.01% | 689 |
|
|
2015
Q2 | $623K | Buy |
5,047
+36
| +0.7% | +$4.54K | 0.01% | 675 |
|
|
2015
Q1 | $591K | Buy |
5,011
+111
| +2% | +$13.3K | 0.01% | 674 |
|
|
2014
Q4 | $582K | Buy |
4,900
+41
| +0.8% | +$4.62K | 0.01% | 654 |
|
|
2014
Q3 | $546K | Buy |
4,859
+53
| +1% | +$5.05K | 0.01% | 657 |
|
|
2014
Q2 | $455K | Buy |
4,806
+66
| +1% | +$4.63K | 0.01% | 711 |
|
|
2014
Q1 | $335K | Buy |
4,740
+1,782
| +60% | +$141K | 0.01% | 765 |
|
|
2013
Q4 | $220K | Buy |
+2,958
| New | +$206K | ﹤0.01% | 809 |
|
|
2013
Q3 | – | Sell |
-6,859
| Closed | -$549K | – | 953 |
|
|
2013
Q2 | $549K | Buy |
+6,859
| New | +$505K | 0.01% | 628 |
|
Other funds holding VRTX
Virginia Retirement Systems's VRTX Position: Q2 2026 in Review
Virginia Retirement Systems held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 94,060 shares worth $46.7M. The position accounts for 0.28% of the portfolio, ranked #95.
Virginia Retirement Systems first reported a position in VRTX in Q2 2013 and has held it in 34 quarters since. The position peaked at $105M in Q2 2023. 1,754 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Virginia Retirement Systems held 94,060 shares of Vertex Pharmaceuticals worth $46.7M as of Q2 2026.
- Virginia Retirement Systems left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
- Vertex Pharmaceuticals made up 0.28% of Virginia Retirement Systems's portfolio in Q2 2026, its #95 holding.
- Virginia Retirement Systems first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 34 quarters since.
- Virginia Retirement Systems's Vertex Pharmaceuticals position peaked at $105M in Q2 2023.
- 1,754 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.